Our findings provide new insights into the anti-cancer potential of DHC and suggest that it may serve as a valuable adjuvant agent to overcome survival signaling and improve the efficacy of TNF-α-based therapeutic strategies in cervical cancer. The gene discussed is TNF; the disease is cervical cancer.